VivoSeq
Other

Labor Analgesia

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Labor Analgesia is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

69/100

Attrition Rate

25/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

32

clinical trials

Completed18 · 56%
Terminated6 · 19%
Withdrawn2 · 6%
Unknown status2 · 6%
Not yet recruiting2 · 6%
Recruiting1 · 3%
Other1 · 3%

Trial Activity

32 trials

Effects of Ropivacaine Concentrations on Prolonged Labor Analgesia
Not yet recruiting··N/A·NCT07007650·100 enrolled
Intrathecal Dexamethasone and Labor Analgesia
Completed··Phase 2·NCT02588417·80 enrolled
Intravenous Remifentanil for Labor Analgesia
Completed·NNanjing Medical University·Phase 4·NCT00710086·1,000 enrolled
Comparing Effectiveness of CSE Versus DPE for Labor Analgesia
Completed··Phase 4·NCT05068661·101 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)